INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYCYTIDINE, AN INHIBITOR OF HTLV-III INFECTIVITY

被引：213

作者：

COONEY, DA ^{[1
]}

DALAL, M ^{[1
]}

MITSUYA, H ^{[1
]}

MCMAHON, JB ^{[1
]}

NADKARNI, M ^{[1
]}

BALZARINI, J ^{[1
]}

BRODER, S ^{[1
]}

JOHNS, DG ^{[1
]}

机构：

[1] NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892

来源：

BIOCHEMICAL PHARMACOLOGY | 1986年 / 35卷 / 13期

关键词：

D O I：

10.1016/0006-2952(86)90571-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2065 / 2068

页数：4

共 8 条

[1] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].

BARRESINOUSSI, F ;

CHERMANN, JC ;

REY, F ;

NUGEYRE, MT ;

CHAMARET, S ;

GRUEST, J ;

DAUGUET, C ;

AXLERBLIN, C ;

VEZINETBRUN, F ;

ROUZIOUX, C ;

ROZENBAUM, W ;

MONTAGNIER, L .

SCIENCE, 1983, 220 (4599) :868-871

[2] FREQUENT DETECTION AND ISOLATION OF CYTOPATHIC RETROVIRUSES (HTLV-III) FROM PATIENTS WITH AIDS AND AT RISK FOR AIDS [J].

GALLO, RC ;

SALAHUDDIN, SZ ;

POPOVIC, M ;

SHEARER, GM ;

KAPLAN, M ;

HAYNES, BF ;

PALKER, TJ ;

REDFIELD, R ;

OLESKE, J ;

SAFAI, B ;

WHITE, G ;

FOSTER, P ;

MARKHAM, PD .

SCIENCE, 1984, 224 (4648) :500-503

[3] STRUCTURAL REQUIREMENTS FOR ENZYMATIC DEAMINATION OF CYTOSINE NUCLEOSIDES [J].

KREIS, W ;

WATANABE, KA ;

FOX, JJ .

HELVETICA CHIMICA ACTA, 1978, 61 (03) :1011-1016

[4]

KRENITSKY TA, 1965, J BIOL CHEM, V240, P1281

[5]

LAUZON GJ, 1978, CANCER RES, V38, P1723

[6] INHIBITION OF THE INVITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HUMAN LYMPHOTROPHIC-T VIRUS "TYPE-III/LYMPHADENOPATHY-ASSOCIATED VIRUS (HTLV-III/LAV) BY 2',3'-DIDEOXYNUCLEOSIDES [J].

MITSUYA, H ;

BRODER, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) :1911-1915

[7]

VOYTEK P, 1977, CANCER RES, V37, P1956

[8] EFFECTS OF 2',3'-DIDEOXYNUCLEOSIDES ON MAMMALIAN-CELLS AND VIRUSES [J].

WAQAR, MA ;

EVANS, MJ ;

MANLY, KF ;

HUGHES, RG ;

HUBERMAN, JA .

JOURNAL OF CELLULAR PHYSIOLOGY, 1984, 121 (02) :402-408

← 1 →